Searle & Co. Abb Vie Inc. Transaction History

Searle & Co.

$396 Million
Q3 2024

A detailed history of Searle & Co. transactions in Abb Vie Inc. stock. As of the latest transaction made, Searle & Co. holds 46,377 shares of ABBV stock, worth $8.49 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares

46,377

Previous 51,274 9.55%

Holding current value

$8.49 Million

Previous $8.79 Million 4.14%

% of portfolio

2.32%

Previous 2.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $802,324 - $976,119	-4,897 Reduced 9.55%	46,377 $9.16 Million
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $700,734 - $818,300	4,527 Added 9.68%	51,274 $8.79 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $316,480 - $356,431	2,300 Added 5.17%	46,747 $7.24 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $45,365 - $54,405	-328 Reduced 0.73%	44,447 $7.19 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $32,731 - $40,610	-248 Reduced 0.55%	44,775 $7.26 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $32,229 - $40,779	300 Added 0.67%	45,023 $6.1 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $6,523 - $7,267	62 Added 0.14%	44,723 $5.04 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $10,230 - $11,262	100 Added 0.22%	44,661 $4.83 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $8,048 - $10,867	100 Added 0.22%	44,561 $4.78 Million
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $280,786 - $375,734	3,827 Added 9.42%	44,461 $4.37 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $225,750 - $342,265	3,500 Added 9.43%	40,634 $3.1 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $510,896 - $639,240	7,083 Added 23.57%	37,134 $3.29 Million
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $4,219 - $5,073	67 Added 0.22%	30,051 $2.28 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $204,327 - $261,177	3,110 Added 11.57%	29,984 $2.18 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $77,850 - $96,010	-1,000 Reduced 3.59%	26,874 $2.48 Million
Q2 2018 Jul 19, 2018	BUY	$89.78 - $106.23 $1.02 Million - $1.21 Million	11,400 Added 69.2%	27,874 $2.58 Million
Q1 2018 Apr 25, 2018	BUY	$92.01 - $123.21 $106,455 - $142,553	1,157 Added 7.55%	16,474 $1.56 Million
Q4 2017 Jan 17, 2018	SELL	$89.56 - $98.21 $54,452 - $59,711	-608 Reduced 3.82%	15,317 $1.48 Million
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $1.11 Million - $1.42 Million	15,925	15,925 $1.42 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

News

Stay updated on Searle & Co. with notifications on news.

Account